276 related articles for article (PubMed ID: 26384561)
41. Keratinocyte differentiation induces APOBEC3A, 3B, and mitochondrial DNA hypermutation.
Wakae K; Nishiyama T; Kondo S; Izuka T; Que L; Chen C; Kase K; Kitamura K; Mohiuddin M; Wang Z; Ahasan MM; Nakamura M; Fujiwara H; Yoshizaki T; Hosomochi K; Tajima A; Nakahara T; Kiyono T; Muramatsu M
Sci Rep; 2018 Jun; 8(1):9745. PubMed ID: 29950685
[TBL] [Abstract][Full Text] [Related]
42. Genetic inhibitors of APOBEC3B-induced mutagenesis.
Mertz TM; Rice-Reynolds E; Nguyen L; Wood A; Cordero C; Bray N; Harcy V; Vyas RK; Mitchell D; Lobachev K; Roberts SA
Genome Res; 2023 Sep; 33(9):1568-1581. PubMed ID: 37532520
[TBL] [Abstract][Full Text] [Related]
43. Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.
Maruyama W; Shirakawa K; Matsui H; Matsumoto T; Yamazaki H; Sarca AD; Kazuma Y; Kobayashi M; Shindo K; Takaori-Kondo A
Biochem Biophys Res Commun; 2016 Sep; 478(3):1466-71. PubMed ID: 27577680
[TBL] [Abstract][Full Text] [Related]
44. The DNA deaminase APOBEC3B interacts with the cell-cycle protein CDK4 and disrupts CDK4-mediated nuclear import of Cyclin D1.
McCann JL; Klein MM; Leland EM; Law EK; Brown WL; Salamango DJ; Harris RS
J Biol Chem; 2019 Aug; 294(32):12099-12111. PubMed ID: 31217276
[TBL] [Abstract][Full Text] [Related]
45. Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks.
Stewart JA; Schauer G; Bhagwat AS
Nucleic Acids Res; 2020 Nov; 48(20):e118. PubMed ID: 33074285
[TBL] [Abstract][Full Text] [Related]
46. HPV11 E6 mutation by overexpression of APOBEC3A and effects of interferon-ω on APOBEC3s and HPV11 E6 expression in HPV11.HaCaT cells.
Wang Y; Li X; Song S; Sun Y; Zhang J; Yu C; Chen W
Virol J; 2017 Nov; 14(1):211. PubMed ID: 29100527
[TBL] [Abstract][Full Text] [Related]
47. p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells.
Periyasamy M; Singh AK; Gemma C; Kranjec C; Farzan R; Leach DA; Navaratnam N; Pálinkás HL; Vértessy BG; Fenton TR; Doorbar J; Fuller-Pace F; Meek DW; Coombes RC; Buluwela L; Ali S
Nucleic Acids Res; 2017 Nov; 45(19):11056-11069. PubMed ID: 28977491
[TBL] [Abstract][Full Text] [Related]
48. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities.
Bulliard Y; Narvaiza I; Bertero A; Peddi S; Röhrig UF; Ortiz M; Zoete V; Castro-Díaz N; Turelli P; Telenti A; Michielin O; Weitzman MD; Trono D
J Virol; 2011 Feb; 85(4):1765-76. PubMed ID: 21123384
[TBL] [Abstract][Full Text] [Related]
49. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
bioRxiv; 2023 Aug; ():. PubMed ID: 37577595
[TBL] [Abstract][Full Text] [Related]
50. m6A demethylation of cytidine deaminase APOBEC3B mRNA orchestrates arsenic-induced mutagenesis.
Gao M; Qi Z; Feng W; Huang H; Xu Z; Dong Z; Xu M; Han J; Kloeber JA; Huang J; Lou Z; Liu S
J Biol Chem; 2022 Feb; 298(2):101563. PubMed ID: 34998823
[TBL] [Abstract][Full Text] [Related]
51. Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication.
Bonvin M; Achermann F; Greeve I; Stroka D; Keogh A; Inderbitzin D; Candinas D; Sommer P; Wain-Hobson S; Vartanian JP; Greeve J
Hepatology; 2006 Jun; 43(6):1364-74. PubMed ID: 16729314
[TBL] [Abstract][Full Text] [Related]
52. APOBEC3B expression in breast cancer cell lines and tumors depends on the estrogen receptor status.
Udquim KI; Zettelmeyer C; Banday AR; Lin SH; Prokunina-Olsson L
Carcinogenesis; 2020 Aug; 41(8):1030-1037. PubMed ID: 31930332
[TBL] [Abstract][Full Text] [Related]
53. Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death.
Mussil B; Suspène R; Aynaud MM; Gauvrit A; Vartanian JP; Wain-Hobson S
PLoS One; 2013; 8(8):e73641. PubMed ID: 23977391
[TBL] [Abstract][Full Text] [Related]
54. APOBEC3B: pathological consequences of an innate immune DNA mutator.
Burns MB; Leonard B; Harris RS
Biomed J; 2015; 38(2):102-10. PubMed ID: 25566802
[TBL] [Abstract][Full Text] [Related]
55. Substrate sequence selectivity of APOBEC3A implicates intra-DNA interactions.
Silvas TV; Hou S; Myint W; Nalivaika E; Somasundaran M; Kelch BA; Matsuo H; Kurt Yilmaz N; Schiffer CA
Sci Rep; 2018 May; 8(1):7511. PubMed ID: 29760455
[TBL] [Abstract][Full Text] [Related]
56. Single-Molecule Force Spectroscopy Studies of APOBEC3A-Single-Stranded DNA Complexes.
Shlyakhtenko LS; Dutta S; Li M; Harris RS; Lyubchenko YL
Biochemistry; 2016 Jun; 55(22):3102-6. PubMed ID: 27182892
[TBL] [Abstract][Full Text] [Related]
57. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase.
Narvaiza I; Linfesty DC; Greener BN; Hakata Y; Pintel DJ; Logue E; Landau NR; Weitzman MD
PLoS Pathog; 2009 May; 5(5):e1000439. PubMed ID: 19461882
[TBL] [Abstract][Full Text] [Related]
58. APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression.
Yamazaki H; Shirakawa K; Matsumoto T; Kazuma Y; Matsui H; Horisawa Y; Stanford E; Sarca AD; Shirakawa R; Shindo K; Takaori-Kondo A
PLoS One; 2020; 15(1):e0223463. PubMed ID: 31914134
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of APOBEC3B Recognition Motifs by NMR Reveals Preferred Substrates.
Liu M; Mallinger A; Tortorici M; Newbatt Y; Richards M; Mirza A; van Montfort RLM; Burke R; Blagg J; Kaserer T
ACS Chem Biol; 2018 Sep; 13(9):2427-2432. PubMed ID: 30130388
[TBL] [Abstract][Full Text] [Related]
60. Enzyme cycling contributes to efficient induction of genome mutagenesis by the cytidine deaminase APOBEC3B.
Adolph MB; Love RP; Feng Y; Chelico L
Nucleic Acids Res; 2017 Nov; 45(20):11925-11940. PubMed ID: 28981865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
